Natasha Love Peoples NP

Recommended Articles

• Common Multiple Sclerosis Treatments: An Overview

  A debilitating disease that was once the face of a crushing and “hopeless” diagnosis has evolved from having one effective treatment to multiple effective treatments. Longtime sufferers who didn’t respond to one medication now have options to try others, to participate in a clinical trial or...

• Can Weight Loss Improve Symptoms Caused by Arthritis?

  Arthritis is the common name given to a group of over a hundred types of diseases affecting the joints. The common symptoms of arthritis include: pain in the joints, inflammation, swelling, stiffness, and reduced motion. While arthritis can affect people of any age group, it is more prevalent in the...

• Does MS Worsen Over Time? How to Cope with MS

  The number of multiple sclerosis patients may not be known, since it is a condition that is not easily diagnosed due to symptoms being unapparent, and because there is no strict requirement for physicians to report cases within their practice. However, it is believed that 2.3 million and more...

• What Do Bumps on the Roof of Your Mouth Mean?

  IntroductionThe presence of bumps and lumps in the mouth is not something uncommon. You may have experienced them in the past, particularly on your lips, back of the throat, or tongue. There are various things that can cause the formation of bumps on the roof of your mouth, but most of them are...

• Keeping Cozy: How Lupus Patients Cope with Raynaud's Phenomenon

  In the United States, about 30 to 40 percent of lupus patients have been found to also suffer from Raynaud's phenomenon. Raynaud's causes a constriction in the arteries supplying blood to the extremities—mostly the fingers and toes, but sometimes also the ears, nose, lips and chin. This causes...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...